Table 2.
Category | Situation |
---|---|
Very High | Poorly controlled patients (HbA1c >8.5%) (Average blood glucose >300 mg/dL) |
Risk | Type 1 Diabetes mellitus |
History of Hypoglycemic unawareness, severe or recurrent hypoglycemia, Diabetic ketoacidosis or hyperosmolar hyperglycemic coma in the last 3 months | |
Acute illness | |
Pre- existing DM in pregnancy or Gestational DM on insulin | |
Immunocompromised patients [HIV, Cancer, PTB, Transplant recipients, on immunosuppressants] | |
Associated co-morbidities like heart failure, recent myocardial infarction, hepatic failure, severe respiratory illness, CKD Stage 4 and 5] | |
Elderly who are ill | |
COVID-19 positive patients, or with history of contact or travel with COVID-19 positive patients. | |
High risk | Moderately controlled patients (HbA1c 7.5-8.5%) (Average blood glucose 150-300 mg/dL) |
Renal insufficiency- CKD stage 3 | |
Pregnant and lactating women- controlled by diet only or metformin | |
Living alone on multiple insulin injections | |
Autonomic neuropathy, moderate to severe micro and microvascular complications | |
Members living in same premises of COVID-19 positive patient | |
Moderate risk | Patients with good glycemic control (HbA1c 7-7.5%) |
On insulin, oral anti-diabetes agents, GLP-1 receptor agonists | |
People living in COVID-19 hotspot areas | |
Low risk | Well controlled patients (HbA1c <7%) |
On lifestyle modification only or monotherapy and healthy |
GLP-1: Glucagon-Like-Peptide, CKD: Chronic kidney disease, DM : Diabetes mellitus, HIV : Human Immunodeficiency virus, PTB : Pulmonary tuberculosis. Adapted from: ADA 2020, IDF 2016, IGDR 2015, IDF-DAR Practical Guidelines, South Asian Consensus Guidelines, ICMR guidelines, South Asian Health Foundation Update